Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHEMED CORPCHE · Entity 3723 | Director · president and CEO | September 28, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHEMED CORP
Report date September 28, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Capital StockSEC Table I · non-derivative | Direct | 66,418 |
Reported balance
After 2026-09-28 transaction · row 1
1 source rowRow 1 · 2026-09-28 · Sale · Disposed 2,000 · Balance 66,418 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $510.93 to $515.12. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2019 Filed May 7, 2019 15:20 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 30,899 | $70.30 Strike: $70.30 | $2,172,199.70 |
DisclosureSEC source: 0001209191-19-027912 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,400 Underlying: capital stock · 30,899 shares Expires 2023-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/8/2014. Read SEC document |
| May 06, 2019 Filed May 7, 2019 15:20 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 6,000 | $331.67 | $1,990,020.00 |
DisclosureSEC source: 0001209191-19-027912 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,318 Read SEC document |
| May 06, 2019 Filed May 7, 2019 15:20 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 17,016 | $328.73 | $5,593,669.68 |
DisclosureSEC source: 0001209191-19-027912 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,318 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 06, 2019 Filed May 7, 2019 15:20 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 30,899 | $70.30 | $2,172,199.70 |
DisclosureSEC source: 0001209191-19-027912 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 19:38 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 2,500 | $135.85 Strike: $135.85 | $339,625.00 |
DisclosureSEC source: 0001209191-19-020972 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,299 Underlying: capital stock · 2,500 shares Expires 2021-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 19:38 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 1,400 | $324.52 | $454,328.00 |
DisclosureSEC source: 0001209191-19-020972 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,435 Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 19:38 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,665 | $326.71 | $543,972.15 |
DisclosureSEC source: 0001209191-19-020972 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,835 Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 19:38 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 2,500 | $135.85 | $339,625.00 |
DisclosureSEC source: 0001209191-19-020972 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 30,000 | $157.36 Strike: $157.36 | $4,720,800.00 |
DisclosureSEC source: 0001209191-19-013949 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,799 Underlying: capital stock · 30,000 shares Expires 2020-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: vesting in three equal annual installments commencing 11/6/2016. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:14 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,000 | $323.47 | $1,617,350.00 |
DisclosureSEC source: 0001209191-19-013949 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,000 Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:14 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 21,094 | $327.43 | $6,906,808.42 |
DisclosureSEC source: 0001209191-19-013949 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:14 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 30,000 | $157.36 | $4,720,800.00 |
DisclosureSEC source: 0001209191-19-013949 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:24 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 4,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012908 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,170 Underlying: capital stock · 4,928 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2019 to December 31, 2021. The determination of the performance level is to be made by March 15, 2022 and earned shares to be delivered thereafter F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2019 to December 31, 2021. The determination of the performance level is to be made by March 15, 2022 and earned shares to be delivered thereafter Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:24 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 2,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012908 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,242 Underlying: capital stock · 2,765 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. F5 · derivative.expiration_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:24 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 2,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012908 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,007 Underlying: capital stock · 2,765 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. F5 · derivative.expiration_date: PSU's awarded February 22, 2016 vest based on achievement of performance targets over a period of January 1, 2016 to December 31, 2018. The determination of the performance level was to be made by March 15, 2019. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:24 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 4,317 | $322.40 | $1,391,800.80 |
DisclosureSEC source: 0001209191-19-012908 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,094 F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:24 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 3,982 | $322.40 | $1,283,796.80 |
DisclosureSEC source: 0001209191-19-012908 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,411 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2016 through December 31, 2018, compared to a defined peer group of companies. The Company's performance ranked in the 70th percentile of that group, yielding an award of 141.7%; including the reinvestment of dividends paid during such period, the award is 144.0% of target. Read SEC document |
| February 22, 2019 Filed Feb 25, 2019 19:24 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 5,621 | $322.40 | $1,812,210.40 |
DisclosureSEC source: 0001209191-19-012908 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2016 through December 31, 2018. The actual performance of 20.52% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 203.3% of target. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 14:09 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 2,500 | $135.85 Strike: $135.85 | $339,625.00 |
DisclosureSEC source: 0001209191-18-058084 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,799 Underlying: capital stock · 2,500 shares Expires 2026-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/04/2017 Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 14:09 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 827 | $315.74 | $261,116.98 |
DisclosureSEC source: 0001209191-18-058084 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,808 Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 14:09 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,673 | $322.39 | $539,358.47 |
DisclosureSEC source: 0001209191-18-058084 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,635 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 14:09 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 2,500 | $135.85 | $339,625.00 |
DisclosureSEC source: 0001209191-18-058084 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 17:20 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 20,000 | $157.36 Strike: $157.36 | $3,147,200.00 |
DisclosureSEC source: 0001209191-18-057086 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,299 Underlying: capital stock · 20,000 shares Expires 2025-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: vesting in three equal annual installments commencing 11/6/2016. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 17:20 UTC | CHEMED CORP CHE · Entity 3723 | Grantstock option(right to buy with tandem tax withholding) · Derivative | 30,000 | $306.70 Strike: $306.70 | $9,201,000.00 |
DisclosureSEC source: 0001209191-18-057086 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,299 Underlying: capital stock · 30,000 shares Expires 2023-11-02 F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019 Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 17:20 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 7,000 | $305.98 | $2,141,860.00 |
DisclosureSEC source: 0001209191-18-057086 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,808 Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 17:20 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 14,485 | $304.06 | $4,404,309.10 |
DisclosureSEC source: 0001209191-18-057086 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,808 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| November 02, 2018 Filed Nov 5, 2018 17:20 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 20,000 | $157.36 | $3,147,200.00 |
DisclosureSEC source: 0001209191-18-057086 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:00 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 20,000 | $157.36 Strike: $157.36 | $3,147,200.00 |
DisclosureSEC source: 0001209191-18-048296 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,299 Underlying: capital stock · 20,000 shares Expires 2025-11-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: vesting in three equal annual installments commencing 11/6/2016. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:00 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 4,000 | $319.50 | $1,278,000.00 |
DisclosureSEC source: 0001209191-18-048296 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,293 Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:00 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 14,198 | $319.58 | $4,537,396.84 |
DisclosureSEC source: 0001209191-18-048296 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,293 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 16:00 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 20,000 | $157.36 | $3,147,200.00 |
DisclosureSEC source: 0001209191-18-048296 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 13:46 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 5,000 | $321.59 | $1,607,950.00 |
DisclosureSEC source: 0001209191-18-038719 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,491 Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 13:46 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 14,000 | $322.51 | $4,515,140.00 |
DisclosureSEC source: 0001209191-18-038719 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,491 Read SEC document |
| May 22, 2018 Filed May 22, 2018 14:33 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 1,079 | $333.53 | $359,878.87 |
DisclosureSEC source: 0001209191-18-032192 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,491 F1 · kind: stock award tax obligation Read SEC document |
| May 09, 2018 Filed May 10, 2018 13:42 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 30,000 | $106.59 Strike: $106.59 | $3,197,700.00 |
DisclosureSEC source: 0001209191-18-029072 · doc4.xml · derivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,299 Underlying: capital stock · 30,000 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/7/2015 Read SEC document |
| May 09, 2018 Filed May 10, 2018 13:42 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $319.22 | $3,192,200.00 |
DisclosureSEC source: 0001209191-18-029072 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,570 Read SEC document |
| May 09, 2018 Filed May 10, 2018 13:42 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 18,616 | $317.17 | $5,904,436.72 |
DisclosureSEC source: 0001209191-18-029072 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,570 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| May 09, 2018 Filed May 10, 2018 13:42 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 30,000 | $106.59 | $3,197,700.00 |
DisclosureSEC source: 0001209191-18-029072 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:22 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 40,000 | $106.59 Strike: $106.59 | $4,263,600.00 |
DisclosureSEC source: 0001209191-18-026048 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,299 Underlying: capital stock · 40,000 shares Expires 2024-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/7/2015 Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:22 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 10,000 | $299.36 | $2,993,600.00 |
DisclosureSEC source: 0001209191-18-026048 · doc4.xml · nonDerivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,186 Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:22 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 12,000 | $299.96 | $3,599,520.00 |
DisclosureSEC source: 0001209191-18-026048 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,186 Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:22 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 25,189 | $302.72 | $7,625,214.08 |
DisclosureSEC source: 0001209191-18-026048 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,186 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| April 24, 2018 Filed Apr 25, 2018 19:22 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 40,000 | $106.59 | $4,263,600.00 |
DisclosureSEC source: 0001209191-18-026048 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 2, 2018 17:51 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative | 20,000 | $70.30 Strike: $70.30 | $1,406,000.00 |
DisclosureSEC source: 0001209191-18-015416 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,299 Underlying: capital stock · 20,000 shares Expires 2023-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/8/2014. Read SEC document |
| March 02, 2018 Filed Mar 2, 2018 17:51 UTC | CHEMED CORP CHE · Entity 3723 | Tax withholdingcapital stock | 11,674 | $258.79 | $3,021,114.46 |
DisclosureSEC source: 0001209191-18-015416 · doc4.xml · nonDerivative · entry 4 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,375 F1 · kind: Payment of purchase price and tax obligation on stock option exercise. Read SEC document |
| March 02, 2018 Filed Mar 2, 2018 17:51 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversioncapital stock | 20,000 | $70.30 | $1,406,000.00 |
DisclosureSEC source: 0001209191-18-015416 · doc4.xml · nonDerivative · entry 3 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 17:51 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $258.68 | $776,040.00 |
DisclosureSEC source: 0001209191-18-015416 · doc4.xml · nonDerivative · entry 2 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,049 Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 17:51 UTC | CHEMED CORP CHE · Entity 3723 | Salecapital stock | 3,000 | $257.31 | $771,930.00 |
DisclosureSEC source: 0001209191-18-015416 · doc4.xml · nonDerivative · entry 1 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,049 Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 15:56 UTC | CHEMED CORP CHE · Entity 3723 | Grantperformance stock units · Derivative | 3,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011150 · doc4.xml · derivative · entry 6 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,772 Underlying: capital stock · 3,928 shares Expires not disclosed F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock F7 · derivative.exercise_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level is to be made by March 15, 2021 and earned shares delivered thereafter. F7 · derivative.expiration_date: PSU's vest based on the extent to which the Company achieves certain performance targets over a period of January 1, 2018 to December 31, 2020. The determination of the performance level is to be made by March 15, 2021 and earned shares delivered thereafter. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 15:56 UTC | CHEMED CORP CHE · Entity 3723 | Exercise / conversionperformance stock units · Derivative | 3,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-011150 · doc4.xml · derivative · entry 5 MCNAMARA KEVIN J · CIK 0001207137 · Director · president and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,844 Underlying: capital stock · 3,094 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee. F5 · derivative.exercise_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. F5 · derivative.expiration_date: PSU's awarded February 20, 2015 vest based on achievement of performance targets over a period of January 1, 2015 to December 31, 2017. The determination of the performance level was to be made by March 15, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.